ETF and index data management specialists
  • Why Ultumus
  • Our Products
    • Global Index Aggregation
    • Global ETF Aggregation
    • PCF Calculation
    • Global Dividend Forecast
  • News & Insights
  • Contact Us

News

Blackrock Thematic

By Bernie Thurston
June 05, 2019

BlackRock is bulking up its thematic suite, listing two new funds targeting popular well-performing niches, both of which track FactSet indexes.


  • iShares Cybersecurity and Tech ETF (IHAK)
  • iShares Genomics Immunology and Healthcare ETF (IDNA)

IHAK, to us, looks basically like a global tech ETF but with some tampering around the edges and a steep fee. IHAK will invest in global companies judged by FactSet to be exposed to cybersecurity. The companies it chooses, which will overwhelmingly come from the tech sector, will be selected with an eye to revenue. 

The fund will rebalance twice a year and reconstituted annually. While the companies can be global, 34 out of 39 at the time of writing are based in the US, the prospectus indicates. IHAK charges 0.47%.

IDNA, from what we can tell, is just a global biotech ETF, but with a try-hard fund name and - again - a steep fee. IDNA begins by using RBICS definitions of the biopharma and healthcare sectors. It then invests in the biggest companies by market cap that FactSet judges to be involved in genomics and immunology. 

The weights of each company are capped at 4%, giving the fund something similar to the equal weight effect of State Street’s $4 billion biotech ETF XBI. The fund rebalances annually and charges 0.47%. 


Contact Us

All posts
About Author
Bernie Thurston

You might also like
MSCI Reclassification of Lebanon from Frontier Markets to Standalone
MSCI Reclassification of Lebanon from Frontier Markets to Standalone
June 05, 2019
MSCI Reclassification of Iceland from Standalone to Frontier Markets
MSCI Reclassification of Iceland from Standalone to Frontier Markets
June 05, 2019
Fighting Fat ETF
Fighting Fat ETF
June 05, 2019
Ultumus Logo

Our market leading technology powers four highly customizable solutions.

Products
  • Index Aggregation
  • ETF Aggregation
  • PCF Calculation
  • Dividend Forecast
Site map
  • Why Ultumus
  • Our Products
  • Insights
  • Contact Us
Contact Us
  • +44 (0) 203 998 2500
  • info@ultumus.com

©2021. All rights reserved